Ontology highlight
ABSTRACT: Objective
This study was devoted to identifying natural thrombin inhibitors from traditional Chinese medicine (TCM) and evaluating its biological activity in vitro and binding characteristics.Methods
A combination strategy containing molecular docking, thrombin inhibition assay, surface plasmon resonance (SPR) and molecular dynamics simulation were applied to verify the study result.Results
Gallic acid was confirmed as a direct thrombin inhibitor with IC50 of 9.07 μmol/L and showed a significant inhibitory effect on thrombin induced platelet aggregation. SPR-based binding studies demonstrated that gallic acid interacted with thrombin with a KD value of 8.29 μmol/L. Molecular dynamics and binding free energy analysis revealed that thrombin-gallic acid system attained equilibrium rapidly with very low fluctuations, the calculated binding free energies was -14.61 kcal/mol. Ala230, Glu232, Ser235, Gly258 and Gly260 were the main amino acid residues responsible for thrombin inhibition by gallic acid, providing a mechanistic basis for further optimization.Conclusion
This study proved that gallic acid is a direct thrombin inhibitor with platelet aggregation inhibitory effect, which could provide a basis for the follow-up research and development for novel thrombin inhibitors.
SUBMITTER: Zhang Y
PROVIDER: S-EPMC9476537 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature
Zhang Yuxin Y Wang Xing X Lu Binan B Gao Yanbin Y Zhang Yanling Y Li Yatong Y Niu Hongjuan H Fan Lu L Pang Zongran Z Qiao Yanjiang Y
Chinese herbal medicines 20210903 2
<h4>Objective</h4>This study was devoted to identifying natural thrombin inhibitors from traditional Chinese medicine (TCM) and evaluating its biological activity <i>in vitro</i> and binding characteristics.<h4>Methods</h4>A combination strategy containing molecular docking, thrombin inhibition assay, surface plasmon resonance (SPR) and molecular dynamics simulation were applied to verify the study result.<h4>Results</h4>Gallic acid was confirmed as a direct thrombin inhibitor with IC<sub>50</su ...[more]